First Page | Document Content | |
---|---|---|
Date: 2015-07-10 08:30:48Eye Clinical pharmacology Medical prescription Patient safety Vitreomacular adhesion Macular hole Macular degeneration Macula of retina | SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) ® JETREA ocriplasmin 2.5 mg/ml Pharmaceutical Services Department of Health and Community ServicesAdd to Reading ListSource URL: www.health.gov.nl.caDownload Document from Source WebsiteFile Size: 174,24 KBShare Document on Facebook |